A detailed history of First Purpose Wealth LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, First Purpose Wealth LLC holds 3,588 shares of ABBV stock, worth $615,413. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,588
Previous 3,646 1.59%
Holding current value
$615,413
Previous $565,000 15.58%
% of portfolio
0.24%
Previous 0.22%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $9,269 - $10,561
-58 Reduced 1.59%
3,588 $653,000
Q4 2023

Apr 22, 2024

SELL
$137.6 - $154.97 $550 - $619
-4 Reduced 0.11%
3,646 $565,000
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $28,989 - $33,559
217 Added 6.32%
3,650 $544,000
Q2 2023

Jul 21, 2023

SELL
$132.51 - $164.9 $6,095 - $7,585
-46 Reduced 1.32%
3,433 $462,000
Q1 2023

May 03, 2023

BUY
$144.61 - $166.54 $319,154 - $367,553
2,207 Added 173.51%
3,479 $554,000
Q4 2022

Jan 26, 2023

BUY
$138.31 - $165.87 $175,930 - $210,986
1,272 New
1,272 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Purpose Wealth LLC Portfolio

Follow First Purpose Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Purpose Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Purpose Wealth LLC with notifications on news.